We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00263783
Recruitment Status : Completed
First Posted : December 9, 2005
Last Update Posted : January 29, 2009
Information provided by:
MedImmune LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2002
  Study Completion Date : June 2002